Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
28 drugs in development
By Therapeutic Area
top 6
R&D Momentum
94/100
Pipeline Velocity
70/100
Trial Completion Rate
70/100
Pipeline Concentration
16/100
Pipeline Freshness
64/100
Strategic Signals
Activity
Last 14 days
Decision-Making Experiences for Culturally Inclusive Dementia Engagement: Dyads and Families (DECIDE: Dyads and Families)
RAD4649-19: Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Feasibility, Acceptability and Adherence of the Fall Prevention Pathways With Remote Monitoring
A Pilot Study of Virtual Rehabilitation After Hematopoietic Cell Transplantation
Proton Beam Radiation Therapy in Patients With Resected N2 Non-Small Cell Lung Cancer
Late Abatacept Conversion in Kidney Transplant Recipients Receiving Belatacept: a Prospective, Randomized Controlled Non-inferiority Trial. IM101-884
Comprehensive Assessment of Histopathologic and Physiologic Profile in Esophageal Motility Disorders
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)